fluorodeoxyglucose f18 has been researched along with Extensively Drug-Resistant Tuberculosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barry, CE; Chen, RY; Cho, SN; Coleman, MT; Dartois, V; Dodd, LE; Flynn, JL; Janssen, C; Kim, Y; Klein, E; Lee, M; Lin, PL; Maiello, P; Marriner, G; Scanga, C; Via, LE; Wang, J | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and Extensively Drug-Resistant Tuberculosis
| Article | Year |
|---|---|
PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis.
Topics: Acetamides; Algorithms; Animals; Anti-Bacterial Agents; Extensively Drug-Resistant Tuberculosis; Fluorodeoxyglucose F18; Humans; Linezolid; Lymph Nodes; Macaca; Multimodal Imaging; Oxazolidinones; Positron-Emission Tomography; Stem Cells; Tomography, X-Ray Computed; Treatment Outcome | 2014 |